First Healthy Participant Dosed in Phase 1 Trial of IMP761 for MS

A Phase 1 clinical trial that’s testing IMP761, an experimental treatment for multiple sclerosis (MS) and other autoimmune conditions, has dosed its first healthy participant, the therapy’s developer has announced. Immutep received regulatory clearance to start the...

Congratulations to Bike the US for MS

A heartfelt congratulations to the Trans Am team for their remarkable cycling journey across the United States of America! They traversed nine states, covering approximately four thousand miles, and ultimately achieved the thrilling milestone of dipping their tires in...

MS and Gut Microbiome Pattern Similar Across US, Asia: Analysis

People with multiple sclerosis show subtle alterations in gut bacteria that seem to be consistent across populations in the U.S. and Asia, a new analysis of previously published studies found. “Our work … establishes a generalized and common gut microbiome pattern in...

Acthar Gel Self-Injection Option Available in US, Mallinckrodt Says

People with multiple sclerosis (MS) and other conditions who use Mallinckrodt‘s treatment Acthar Gel(repository corticotropin injection) now have a self-injection option, the company said. Acthar Gel Single-Dose Pre-filled SelfJect is available in two dosages — 40 USP...

Seasonal Life Hacks for MS

Living with multiple sclerosis (MS) can be tough because it brings challenges to our everyday life. It’s like trying to do regular things when your body and mind are not always cooperating. That’s where life hacks come in. Life hacks for those with MS are...

Cognitive Impairments Affect About a Third of RRMS Patients: Analysis

About a third of people with relapsing-remitting multiple sclerosis (RRMS) exhibit cognitive impairments, according to a review by Australian researchers of 50 previously published studies. The findings suggest that cognitive issues might be somewhat less common in...